These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8665999

  • 21. Simultaneous quantitation of d7-nefazodone, nefazodone, d7-hydroxynefazodone, hydroxynefazodone, m-chlorophenylpiperazine and triazole-dione in human plasma by liquid chromatographic-mass spectrometry.
    Yao M, Srinivas NR.
    Biomed Chromatogr; 2000 Apr; 14(2):106-12. PubMed ID: 10694704
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetic evaluation of co-administration of nefazodone and lithium in healthy subjects.
    Laroudie C, Salazar DE, Cosson JP, Cheuvart B, Istin B, Girault J, Ingrand I, Decourt JP.
    Eur J Clin Pharmacol; 1999 Feb; 54(12):923-8. PubMed ID: 10192752
    [Abstract] [Full Text] [Related]

  • 23. Clinical pharmacokinetics of nefazodone.
    Greene DS, Barbhaiya RH.
    Clin Pharmacokinet; 1997 Oct; 33(4):260-75. PubMed ID: 9342502
    [Abstract] [Full Text] [Related]

  • 24. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ, Wilner K, Colburn W, Haug-Pihale G, Rouviex B.
    Br J Clin Pharmacol; 2002 Oct; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
    Barbhaiya RH, Shukla UA, Greene DS, Breul HP, Midha KK.
    J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents.
    Nacca A, Guiso G, Fracasso C, Cervo L, Caccia S.
    Br J Pharmacol; 1998 Dec; 125(7):1617-23. PubMed ID: 9884092
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions.
    von Moltke LL, Greenblatt DJ, Granda BW, Grassi JM, Schmider J, Harmatz JS, Shader RI.
    Psychopharmacology (Berl); 1999 Jul; 145(1):113-22. PubMed ID: 10445380
    [Abstract] [Full Text] [Related]

  • 33. High-throughput quantitation of nefazodone and its metabolites in human plasma by high flow direct-injection LC-MS/MS.
    Mao Y, Huang MQ, Xia YQ, Jemal M.
    J Pharm Biomed Anal; 2007 Apr 11; 43(5):1808-19. PubMed ID: 17236738
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.
    Srinivas NR, Shyu WC, Gleason C, Schuster A, Greene DS, Barbhaiya RH.
    Clin Pharmacol Ther; 1997 Oct 11; 62(4):408-16. PubMed ID: 9357392
    [Abstract] [Full Text] [Related]

  • 36. Carbamazepine-nefazodone interaction in healthy subjects.
    Laroudie C, Salazar DE, Cosson JP, Cheuvart B, Istin B, Girault J, Ingrand I, Decourt JP.
    J Clin Psychopharmacol; 2000 Feb 11; 20(1):46-53. PubMed ID: 10653208
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects.
    Marino MR, Langenbacher KM, Hammett JL, Nichola P, Uderman HD.
    J Clin Psychopharmacol; 1997 Feb 11; 17(1):27-33. PubMed ID: 9004054
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of various factors on steady state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine.
    Ishida M, Otani K, Kaneko S, Ohkubo T, Osanai T, Yasui N, Mihara K, Higuchi H, Sugawara K.
    Int Clin Psychopharmacol; 1995 Sep 11; 10(3):143-6. PubMed ID: 8675966
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.